Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
HIV integrase inhibitors in ART-experienced patients.
In-depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early HIV-1 infection.
Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides.
Towards an HIV cure: a global scientific strategy.
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
HIV model parameter estimates from interruption trial data including drug efficacy and reservoir dynamics.
The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry.
Raltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recovery.
Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
Combined antiretroviral therapy and immune pressure lead to in vivo HIV-1 recombination with ancestral viral genomes.